Atom Investors LP Editas Medicine, Inc. Transaction History
Atom Investors LP
- $769 Million
- Q1 2025
A detailed history of Atom Investors LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Atom Investors LP holds 10,275 shares of EDIT stock, worth $26,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,275Holding current value
$26,612% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
223Shares Held
48.5MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$20.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.47MShares$19.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$6.89 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$6.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.94MShares$5.03 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $178M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...